Number needed to treat (NNT) as a drug efficacy measure: Zoledronic acid (ZOL) for early hormone-responsive breast cancer in the ABCSG-12 trial

M Gnant; B Mlineritsch; Walter Schippinger; Gero Luschin-Ebengreuth; G Steger; Vesna Bjelic-Radisic; R Jakesz; E Kubista; C Marth; R Greil

doi:10.1016/S0960-9776(09)70187-0

Number needed to treat (NNT) as a drug efficacy measure: Zoledronic acid (ZOL) for early hormone-responsive breast cancer in the ABCSG-12 trial

M Gnant
, B Mlineritsch
, Walter Schippinger
, Gero Luschin-Ebengreuth
, G Steger
, Vesna Bjelic-Radisic
, R Jakesz
, E Kubista
, C Marth
, R Greil

Research output: Contribution to journal › Conference abstract

Original language	English
Journal	Breast
DOIs	https://doi.org/10.1016/S0960-9776(09)70187-0
Publication status	Published - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

DOI

10.1016/S0960-9776(09)70187-0

Cite this

@article{6201679146b348688cdaa08db6d399d1,

title = "Number needed to treat (NNT) as a drug efficacy measure: Zoledronic acid (ZOL) for early hormone-responsive breast cancer in the ABCSG-12 trial",

author = "M Gnant and B Mlineritsch and Walter Schippinger and Gero Luschin-Ebengreuth and G Steger and Vesna Bjelic-Radisic and R Jakesz and E Kubista and C Marth and R Greil",

year = "2009",

doi = "10.1016/S0960-9776(09)70187-0",

language = "English",

journal = "Breast",

issn = "0960-9776",

publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Number needed to treat (NNT) as a drug efficacy measure: Zoledronic acid (ZOL) for early hormone-responsive breast cancer in the ABCSG-12 trial

AU - Gnant, M

AU - Mlineritsch, B

AU - Schippinger, Walter

AU - Luschin-Ebengreuth, Gero

AU - Steger, G

AU - Bjelic-Radisic, Vesna

AU - Jakesz, R

AU - Kubista, E

AU - Marth, C

AU - Greil, R

PY - 2009

Y1 - 2009

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:266149200177

U2 - 10.1016/S0960-9776(09)70187-0

DO - 10.1016/S0960-9776(09)70187-0

M3 - Conference abstract

SN - 0960-9776

JO - Breast

JF - Breast

ER -

Number needed to treat (NNT) as a drug efficacy measure: Zoledronic acid (ZOL) for early hormone-responsive breast cancer in the ABCSG-12 trial

UN SDGs

DOI

Links

Cite this